Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
Cipla
US Department of Justice
Teva
Cantor Fitzgerald
Mallinckrodt
UBS
Citi

Generated: December 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006170

« Back to Dashboard

NDA 006170 describes HYPROTIGEN 5%, which is a drug marketed by B Braun and is included in one NDA. Additional details are available on the HYPROTIGEN 5% profile page.

The generic ingredient in HYPROTIGEN 5% is protein hydrolysate. There are thirty-eight drug master file entries for this compound. Additional details are available on the protein hydrolysate profile page.
Summary for 006170
Tradename:HYPROTIGEN 5%
Applicant:B Braun
Ingredient:protein hydrolysate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength5%
Approval Date:Jan 10, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
QuintilesIMS
Farmers Insurance
Cantor Fitzgerald
Accenture
Dow
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.